John R Glass - Net Worth and Insider Trading
John R Glass Net Worth
The estimated net worth of John R Glass is at least $21,600 dollars as of 2024-11-10. John R Glass is the See Remarks of Provectus Biopharmaceuticals Inc and owns about 200,000 shares of Provectus Biopharmaceuticals Inc (PVCT) stock worth over $21,600. Details can be seen in John R Glass's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John R Glass has not made any transactions after 2017-12-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of John R Glass
John R Glass Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John R Glass owns 1 companies in total, including Provectus Biopharmaceuticals Inc (PVCT) .
Click here to see the complete history of John R Glass’s form 4 insider trades.
Insider Ownership Summary of John R Glass
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PVCT | Provectus Biopharmaceuticals Inc | 2017-12-14 | See Remarks |
John R Glass Latest Holdings Summary
John R Glass currently owns a total of 1 stock. John R Glass owns 200,000 shares of Provectus Biopharmaceuticals Inc (PVCT) as of December 14, 2017, with a value of $21,600.
Latest Holdings of John R Glass
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PVCT | Provectus Biopharmaceuticals Inc | 2017-12-14 | 200,000 | 0.11 | 21,600 |
Holding Weightings of John R Glass
John R Glass Form 4 Trading Tracker
According to the SEC Form 4 filings, John R Glass has made a total of 0 transactions in Provectus Biopharmaceuticals Inc (PVCT) over the past 5 years. The most-recent trade in Provectus Biopharmaceuticals Inc is the acquisition of 200,000 shares on December 14, 2017, which cost John R Glass around $10,000.
Insider Trading History of John R Glass
- 1
John R Glass Trading Performance
GuruFocus tracks the stock performance after each of John R Glass's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John R Glass is 16.67%. GuruFocus also compares John R Glass's trading performance to market benchmark return within the same time period. The performance of stocks bought by John R Glass within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how John R Glass's insider trading performs compared to the benchmark.
Performance of John R Glass
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 16.67 |  | | | | |
| Relative Return to S&P 500(%) | 11.61 | | | | | |
John R Glass Ownership Network
Ownership Network List of John R Glass
Ownership Network Relation of John R Glass
John R Glass Owned Company Details
What does Provectus Biopharmaceuticals Inc do?
Who are the key executives at Provectus Biopharmaceuticals Inc?
John R Glass is the See Remarks of Provectus Biopharmaceuticals Inc. Other key executives at Provectus Biopharmaceuticals Inc include 10 percent owner Jeffrey Allen Morris , Chief Financial Officer Heather Raines , and Interim CEO & CFO & COO Peter R Culpepper .
Provectus Biopharmaceuticals Inc (PVCT) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Provectus Biopharmaceuticals Inc (PVCT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Provectus Biopharmaceuticals Inc (PVCT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Provectus Biopharmaceuticals Inc (PVCT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Provectus Biopharmaceuticals Inc Insider Transactions
John R Glass Mailing Address
Above is the net worth, insider trading, and ownership report for John R Glass. You might contact John R Glass via mailing address: 7327 Oak Ridge Highway Suite A, Knoxville Tn 37931.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
